Mylan (MYL) Enters Agreement with Gilead (GILD) to Produce Generic HIV/AIDS Therapies Containing Emtricitabine

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/21/2026

1. WMT
2. ROST
3. AAP
4. SPY
5. NVDA
6. AVGO
7. BJ
8. OSIS
9. HD
10. SFNC

Go back to Mylan (MYL) Enters Agreement with Gilead (GILD) to Produce Generic HIV/AIDS Therapies Containing Emtricitabine
Gilead Sciences (NASDAQ: GILD) Delayed: 143.44 --0 (-0%)
Previous Close $143.44    52 Week High $108.63 
Open $143.44    52 Week Low $71.39 
Day High $143.44    P/E 79.25 
Day Low $143.44    EPS $1.81 
Volume 1,969       

Mylan Inc. (NASDAQ: MYL) Delayed: 15.86 --0 (-0%)
Previous Close $15.86    52 Week High $55.51 
Open $10.56    52 Week Low $33.60 
Day High $15.86    P/E 10.43 
Day Low $15.86    EPS $1.52 
Volume 45,581